ММВБ 3 115 1,3%  Nasdaq 9 817 0,9%  Биткойн 9 562 -0,5%  USD/RUB 63,7445 0,3% 
РТС 1 542 1,8%  S&P500 3 386 0,5%  Нефть 59,2 -0,2%  EUR/RUB 68,8290 0,2% 
Dow 29 348 0,4%  FTSE100 7 457 1,0%  EUR/USD 1,0798 -0,1% 

Курс акций Translate Bio [ISIN: US89374L1044]

купить
продать

Translate Bio Inc Registered Shs - Профиль

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidates include MRT5005 for the treatment of cystic fibrosis; and for the treatment of ornithine transcarbamylase deficiency. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.

Акционеры

Название Доля (%)
Freefloat66,14
The Baupost Group LLC29,24
The Baupost Group LLC29,24
Takeda Pharmaceutical Co., Ltd.15,68
Fidelity Management & Research Co. LLC14,64
Fidelity Management & Research Co. LLC13,59
GlaxoSmithKline Plc7,06
Atlas Venture Advisors, Inc.6,54
Atlas Venture, Inc.6,53
RTW Investments LP5,51
RTW Investments LP5,25
Fidelity Growth Company Fund5,14
Merck Capital Ventures LLC4,15
Omega Fund Management LLC4,06
Omega Fund Management LLC4,06

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент